Graph AI raises $13.3M for patient safety

Graph AI raised a $13.3 million Series A led by Insight Partners to expand Graph Safety, its AI-native pharmacovigilance platform, across the United States and Europe, according to the financing announcement. The company says live deployments cut adverse-event case processing from more than three hours to under 10 minutes, while keeping validation controls, audit trails, and human oversight. Pharma operators should treat this as a narrow workflow-automation signal—not a license to remove review—and compare traceable case quality against the clinical evidence gate in Google’s AMIE video study.